VTD promotes cell death in CRC cells in a UBXN2A‐dependent manner and acts synergistically with chemotherapeutic agents (e.g., 5‐fluorouracil) (Abdullah et al., 2015a; Sane et al., 2016). Here, UBXN2A is linked to colorectal carcinoma.